[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
[ Tue, Feb 21st 2023 ]: WOPRAI
Michael King Initiated (ALNY) at Strong Buy and Held Target at $304 on, Feb 21st, 2023
Michael King of EF Hutton, Initiated "Alnylam Pharmaceuticals, Inc." (ALNY) at Strong Buy and Held Target at $304 on, Feb 21st, 2023.
Michael has made no other calls on ALNY in the last 4 months.
There are 8 other peers that have a rating on ALNY. Out of the 8 peers that are also analyzing ALNY, 3 agree with Michael's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Mani Foroohar of "SVB Leerink" Maintained at Hold with Decreased Target to $143 on, Monday, January 23rd, 2023
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $210 on, Friday, October 28th, 2022
- Jessica Fye of "JP Morgan" Maintained at Hold with Decreased Target to $200 on, Monday, October 24th, 2022
These are the ratings of the 5 analyists that currently disagree with Michael
- Whitney Ijem of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $310 on, Wednesday, January 18th, 2023
- Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $253 on, Friday, December 16th, 2022
- Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $415 on, Wednesday, November 2nd, 2022
- Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $270 on, Friday, October 28th, 2022
- Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $236 on, Friday, October 28th, 2022